All Stories

  1. Association between chronic viral hepatitis and metabolic syndrome in southern Taiwan: a large population-based study
  2. Stratification of hepatocellular carcinoma risk through modified FIB-4 index in chronic hepatitis B patients on entecavir therapy
  3. A combination of the on-treatment FIB-4 and alpha-foetoprotein predicts clinical outcomes in cirrhotic patients receiving entecavir
  4. Role of hepatitis B surface antigen in hepatitis B virus relapse after entecavir or tenofovir prophylaxis in patients undergoing cancer chemotherapy
  5. The association between steatosis and diabetes with hepatocellular carcinoma in non-genotype 3 chronic hepatitis C patients
  6. Albumin-Bilirubin grade predicts prognosis of HCC patients with sorafenib use
  7. Hepatitis B surface antigen loss and clinical outcomes between HBeAg-negative cirrhosis patients who discontinued or continued nucleoside analogue therapy
  8. Validation and modification of a proposed substaging system for patients with intermediate hepatocellular carcinoma
  9. Sorafenib achieves complete response of advance HCC
  10. Baseline and serial liver stiffness measurement in prediction of portal hypertension progression for patients with compensated cirrhosis